At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MultiCenter Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy in Patients With Anterior Acute Myocardial Infarction ≤ Six Hours After Symptom Onset and Successful Reperfusion (Via PCI)
In Brief
A clinical study evaluating SuperSaturated Oxygen (SS02) Therapy for Anterior Wall Acute Myocardial Infarction. Completed, enrolled 20 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the feasibility of the delivery of SuperSaturated Oxygen (SSO2) Therapy for 60 minutes selectively into the left main coronary artery (LMCA). The therapy will be delivered with a commercially available qualified SSO2 delivery catheter used with the TherOx® DownStream® System and Cartridge in the treatment of patients presenting with an anterior acute myocardial infarction (heart attack) ≤ six hours after symptom onset with successful reperfusion (via PCI).
Study Details
Timeline
Interventions
Delivery of SSO2 Therapy for 60 minutes selectively into the left main coronary artery (LMCA) using the TherOx DownStream System along with a single use disposable device called the TherOx DownStream Cartridge and a commercially available, qualified SSO2 delivery catheter